USPTO 2015–2025 USPTO PatentsView US Corporation

ZOLL Medical Corporation

USPTO PatentsView assignee record — 740 granted patents across 60 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

740
Total patents granted
60
CPC technology areas
24.4
Avg claims per patent
+56%
5-year filing velocity

Portfolio overview

ZOLL Medical Corporation has been granted 740 US utility patents between 2015 and 2025, placing ZOLL Medical Corporation at rank #599 across all assignees tracked by PlainPatent. This portfolio spans 60 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.4 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, ZOLL Medical Corporation is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 69.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 451 grants, compared with 289 in the 2015–2019 window — a +56% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ZOLL Medical Corporation's 24.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 60 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ZOLL Medical Corporation against peers pursuing similar technology classes.

How does ZOLL compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows ZOLL holds 740 patents — placing it at rank #599 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

20406080100 20152016201720182019202020212022202320242025 64
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
ZOLL Medical Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 38 5.1%
2016 57 7.7%
2017 55 7.4%
2018 65 8.8%
2019 74 10.0%
2020 70 9.5%
2021 89 12.0%
2022 64 8.6%
2023 77 10.4%
2024 87 11.8%
2025 64 8.6%

Which technologies does ZOLL Medical Corporation patent most?

Top 15 of 60 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#599

Across all tracked assignees

Innovation Score

69.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does ZOLL Medical Corporation hold?
ZOLL Medical Corporation holds 740 US granted patents filed between 2015 and 2025, spanning 60 technology areas.
What is ZOLL Medical Corporation's Innovation Score?
ZOLL Medical Corporation has an Innovation Score of 69.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does ZOLL Medical Corporation focus on?
ZOLL Medical Corporation's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 556 patents. The company has filed patents in 60 CPC subclasses total.
Is ZOLL Medical Corporation's patent filing rate increasing or decreasing?
ZOLL Medical Corporation's recent filing velocity is +56% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for ZOLL Medical Corporation's patents?
ZOLL Medical Corporation's patents average 24.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the ZOLL Medical Corporation patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope